12 June, 2018 in Business Economics, Commentary / 0 Comments Tariffs Are A Clear and Present Danger To The U.S. Economy
05 June, 2018 in Business Economics, Commentary / 0 Comments Embracing Competition To Empower Biosimilars
05 June, 2018 in Business Economics, Healthcare, Study / 0 Comments New Study: Patients, Employers and Taxpayers Could Save Significantly if Barriers to Biosimilars Removed
31 May, 2018 in Blog, Business Economics / 0 Comments The Anti-Growth Tariffs Are a Clear and Present Danger to Our Future Economic Prosperity
18 May, 2018 in Commentary, Healthcare / 0 Comments North Carolina’s Fiscally Irresponsible Medicaid Reversal
17 May, 2018 in Business Economics, Commentary / 0 Comments Pharmaceutical Price Controls Will Not Improve Health Care Outcomes in Illinois
15 May, 2018 in Business Economics, Commentary / 0 Comments Federal Government Must Revamp Spending To Maximize Economic Growth
08 May, 2018 in Business Economics, Commentary / 0 Comments Creating an Affordable Health Care System Requires More than Rounding Up the Usual Suspects
02 May, 2018 in Business Economics, Featured Homebox1, Study / 0 Comments How Much Should We Spend? New PRI Report Offers the 15% Solution
